AAPS 2023: interviews from the floor with Priya Muralidharan

Awareness Interviews Professional development

During the American Association of Pharmaceutical Scientists (AAPS) PharmSci 360 2023 conference, Bioanalysis Zone caught up with industry experts across numerous disciplines to discuss their involvement with AAPS and their research. In this interview, we spoke to Associate Principal Scientist and 2023 Chair of the Women in Pharmaceutical Sciences Community, Priya Muralidharan, about the challenges women in scientific roles experience when trying to achieve work-life balance and the tools available to help maintain this balance.

Disclaimer: The opinions expressed in this interview are those of the author and do not necessarily reflect the views of Bioanalysis Zone or Taylor & Francis Group.

Speaker

Priya Muralidharan, PhD
Associate Principal Scientist
AstraZeneca (Cambridge, UK)

Priya Muralidharan received Masters in Pharmaceutical Engineering degree from New Jersey Institute of Technology and Doctorate in Pharmaceutical Sciences from the University of Arizona (both US). Priya is experienced in the formulation and product development of small molecules and biologics for inhalation and parenteral delivery. Currently, she works as an Associate Principal Scientist at AstraZeneca leading innovative product/process development. Priya led the AAPS Women in Pharmaceutical Sciences Community as Chair in 2023. She has a significant publication record and serves as a peer-reviewer for leading pharmaceutical journals. During her free time, Priya enjoys dancing, biking, playing sports/board games and completely adores the time she spends with her family

Interested in learning more about PharmSci 360? View our conference report here.

About AAPS

American Association of Pharmaceutical Scientists (AAPS) is a non-profit association of more than 7000 scientists and professionals employed in academia, industry, regulatory and other research related to the pharmaceutical sciences worldwide. Its mission is to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health, which members pursue through four peer-reviewed journals and a variety of events in person and online.